Prothena Corporation plc
PRTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,415 | $4,420 | $2,828 | $2,123 |
| % Growth | -45.4% | 56.3% | 33.2% | – |
| Cost of Goods Sold | $28,938 | $0 | $0 | $0 |
| Gross Profit | -$26,523 | $4,420 | $2,828 | $2,123 |
| % Margin | -1,098.3% | 100% | 100% | 100% |
| R&D Expenses | $28,938 | $40,517 | $50,811 | $50,172 |
| G&A Expenses | $13,238 | $15,910 | $17,598 | $16,848 |
| SG&A Expenses | $13,238 | $15,910 | $17,598 | $16,848 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$28,459 | $32,609 | $0 | $0 |
| Operating Expenses | $13,717 | $89,036 | $68,409 | $67,020 |
| Operating Income | -$40,240 | -$84,616 | -$65,581 | -$64,897 |
| % Margin | -1,666.3% | -1,914.4% | -2,319% | -3,056.9% |
| Other Income/Exp. Net | $4,070 | $3,651 | $4,208 | $5,396 |
| Pre-Tax Income | -$36,170 | -$80,965 | -$61,373 | -$59,501 |
| Tax Expense | $371 | $44,802 | -$1,178 | -$1,545 |
| Net Income | -$36,541 | -$125,767 | -$60,195 | -$57,956 |
| % Margin | -1,513.1% | -2,845.4% | -2,128.5% | -2,729.9% |
| EPS | -0.68 | -2.34 | -1.12 | -1.08 |
| % Growth | 70.9% | -108.9% | -3.7% | – |
| EPS Diluted | -0.68 | -2.34 | -1.12 | -1.08 |
| Weighted Avg Shares Out | 53,830 | 53,827 | 53,827 | 53,815 |
| Weighted Avg Shares Out Dil | 53,830 | 53,827 | 53,827 | 53,815 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,351 | $3,794 | $4,348 | $5,387 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $229 | $225 | $223 | $221 |
| EBITDA | -$35,941 | -$51,782 | -$65,358 | -$64,676 |
| % Margin | -1,488.2% | -1,171.5% | -2,311.1% | -3,046.4% |